Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, ...

Cybin CEO Doug Drysdale discusses learnings from psychedelic drug clinical trial missteps, provides examples of the benefits ...

Terns Pharmaceuticals aims to improve upon currently marketed therapies in CML and obesity, using internally discovered small ...

Over the last year, I’ve settled into my role as CEO of Pacira BioSciences, a company that’s been leading the way in non-opioid pain therapies for years before I took the helm. During my tenure here, ...